Provided by Tiger Trade Technology Pte. Ltd.

BAIYUNSHAN PH

15.070
-0.200-1.31%
Volume:628.00K
Turnover:9.46M
Market Cap:24.50B
PE:7.04
High:15.160
Open:15.110
Low:15.020
Close:15.270
52wk High:19.716
52wk Low:14.000
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:1.11
T/O Rate:0.29%
Dividend:0.96
Dividend Rate:6.34%
EPS(LYR):2.141
ROE:7.43%
ROA:2.37%
PB:0.53
PE(LYR):7.04
PS:0.27

Loading ...

Baiyunshan Pharma: May 2026 Monthly Return Shows Stable Share Capital, Full Public Float Compliance

Bulletin Express
·
Jun 02

Baiyunshan Pharmaceutical Gains China's Nod for Influenza Antiviral Suspension

MT Newswires Live
·
Jun 02

Key Corporate Updates from Hong Kong-Listed Firms: Drug Approvals, A-Share Plans, and May Sales Figures

Stock News
·
Jun 02

Baiyunshan Pharma Declares FY2025 Final Dividend of RMB 0.45 per Share; Payment Slated for 17 July 2026

Bulletin Express
·
May 29

BAIYUNSHAN PH to Distribute Final Dividend of HK$0.5162 per Share on July 17

Stock News
·
May 29

Guangzhou Baiyunshan Pharmaceutical Announces Updated Board Composition and Committee Structure

Bulletin Express
·
May 29

BAIYUNSHAN PH (00874) Appoints Chen Jiehui as Chairman and Legal Representative

Stock News
·
May 29

Baiyunshan's First Report Under Li Xiaojun Reveals Q4 Loss, Cash Shortfall Against Debt, and High Receivables

Deep News
·
May 26

BAIYUNSHAN PH (00874) Announces Completion of RMB 10 Billion Receivables Securitization by Guangzhou Pharmaceutical

Stock News
·
May 22

Guangzhou Baiyunshan Pharmaceutical - Letter Confirms Disposal of Initial Underlying Assets of Gp Corp. , Receipt of RMB1 Bln

THOMSON REUTERS
·
May 22

Guangzhou Baiyunshan Pharmaceutical - Gp Corp. Entered Into Completion Confirmation Letter With Industrial Securities Asset Management

THOMSON REUTERS
·
May 22

Baiyunshan (00874): Liu Hong Elected as Employee Representative Director for Tenth Board Term

Stock News
·
May 15

Baiyunshan Pharmaceutical Gets Supplementary Approvals for Two Drugs

MT Newswires Live
·
May 12

BAIYUNSHAN PH's Subsidiary Receives Approval for Supplemental Applications of Cefuroxime Sodium and Candesartan Cilexetil Tablets

Stock News
·
May 11

Baiyunshan Pharma Tables 10 Director Nominations for Upcoming Three-Year Board Term

Bulletin Express
·
May 07

BAIYUNSHAN PH (00874) Proposes Director Re-election and New Appointments

Stock News
·
May 07

Baiyunshan Pharmaceutical Sets AGM for 29 May 2026; Agenda Covers 2025 Results, Profit Distribution and Tenth-Board Elections

Bulletin Express
·
May 07

Baiyunshan Pharma Sets 29 May AGM; Seeks RMB 64.12 Billion Credit Lines, Proposes Board Reshuffle and Auditor Re-appointment

Bulletin Express
·
May 07

BAIYUNSHAN PH Reports First-Quarter Net Profit of RMB 1.78 Billion, Down 2.06% Year-on-Year

Stock News
·
Apr 27

Guangzhou Baiyunshan Pharmaceutical - Qtrly Income From Operations RMB23.28 Bln

THOMSON REUTERS
·
Apr 27